Centerpulse
This article was originally published in The Gray Sheet
Executive Summary
An additional $45 mil. will be allotted for legal expenses in the second quarter, incurred from the firm's March 2002 hip and knee recall and U.S. class action settlement (1"The Gray Sheet" June 3, 2002, p. 6). While litigation expenses now top $918 mil., Centerpulse maintains the increase will not affect the terms and conditions of pending acquisition bids from Smith & Nephew ($2.3 bil.) and Zimmer ($3.2 bil.) (2"The Gray Sheet" May 26, 2003, p. 3)...
You may also be interested in...
Centerpulse/Sulzer Cuts Settlement Opt-Outs To 87, Sidesteps Bankruptcy
Centerpulse plans to "aggressively defend" in court any outstanding claims related to its Inter-Op hip implant and Natural Knee II recalls that were not part of a class settlement, but the firm has not ruled out the possibility of settling those claims out of court
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.